XELR8 Holdings (BZI) Analysis - Stock Analysis, Stock Ratings

InvestorGuide Stock Analysis

BZI has yet to be featured as an InvestorGuide.com Stock of the Day. But read about these related stocks from the Drugs Sector:

CVS is Pained by its Weak Pharmacy Benefits Division
Excerpt from the InvestorGuide.com Stock of the Day on 11/5/2009

CVS Caremark Corp. is a company that wears many different hats. The company runs a network of over 7,000 CVS drugstores, maintains pharmacy locations within those drugstores, and now also owns a pharmacy benefits company (Caremark). Although these businesses are very closely related, the acquisition of Caremark was questioned by many investors. Investors saw this as a risky move which might help the company, but one which might also cause more pain than it was worth. This quarter, as it has been with every quarter since the acquisition, investors and analysts waited to see if the results would help them determine if this was indeed a good decision or not. And based on the response of the investors after the earnings announcement, they got a very clear answer.

If you asked the analysts, CVS posted a strong third quarter report, beating analysts' expectations. Profit rose 39%, jumping from 50 cents to 71 cents per share, while analysts had been expecting 64 cents per share. Revenue also rose, from $20.86 billion to $24.64 billion, just beating the estimates of $24.61 billion. Revenue from the drugstore division rose almost 18%, and revenue from the pharmacy benefits division rose over 23%. Looking a little closer, same-store retail sales rose 5.7%, with same-store pharmacy sales rising 8%, which combined with the other numbers paint a rosy picture for CVS Caremark. More >

Subscribe to the Stock of the Day!

InvestorGuide Stock of the Day RSS feed

Upcoming Acquisition between Merck and Schering-Plough Appears Healthy
Excerpt from the InvestorGuide.com Stock of the Day on 10/22/2009

Since the beginning of this year, there has been a lot of attention given to drugmaker Merck & Co., ever since the company announced in March that they would be merging with Schering-Plough Corporation (SGP: Charts, News, Offers). The deal has been carefully analyzed, going through all the regular regulatory channels. And as the end of the year approaches, and the final stages of the deal loom just around the corner, the big question is: Are these two companies in good health as they head towards the merger, or could there be larger issues plaguing this arrangement? More >

Walgreen Receives a Shot of Success with Pharmaceuticals
Excerpt from the InvestorGuide.com Stock of the Day on 9/29/2009

The Walgreen Company beat out Wall Street predications with its fourth quarter performance today. Although profit declined from this time last year, it managed to top analysts' expectations. Walgreen also saw its overall sales rise 7.6 percent. The largest U.S. drugstore has been battling increasing competition from CVS (CVS: Charts, News, Offers) and Rite Aid (RAD: Charts, News, Offers), but its fourth quarter report comes as promising news for most investors. How was Walgreen able to post such an impressive quarterly performance? What are the drugstore chain's plans for the future? More >

Rite Aid Needs More Than a Band-Aid to Fix Its Problems
Excerpt from the InvestorGuide.com Stock of the Day on 9/24/2009

Just a little over two years ago, in June 2007, Rite Aid was sitting pretty. The company had just completed a major acquisition, making Rite Aid the third largest drug store, and had announced unexpectedly strong profits. Analysts thought they might be unstoppable, and that Rite Aid would be giving its competitors a run for their money. However, two years later, the company is in a much different position. What does the future look like for Rite Aid, and is there a prescription that can help this ailing company? More >